CD31 mismatching affects marrow transplantation outcome

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 9, 2001, Pages 503-512

  Grumet, F Carl ^a   Hiraki, Debra D ^a   Brown, Byron Wm ^a   Zehnder, James L ^a   Zacks, Eran S ^a   Draksharapu, Aparna ^a   Parnes, Joshua ^a   Negrin, Robert S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; CD31; Graft versus host disease; mHag; Minor histocompatibility antigens

Indexed keywords

CD31 ANTIGEN; CYCLOSPORIN; DNA; HLA A2 ANTIGEN; HLA B ANTIGEN; METHOTREXATE; MINOR HISTOCOMPATIBILITY ANTIGEN; PREDNISONE;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLELE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW; CHILD; CHRONIC DISEASE; CODON; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; DONOR; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RECIPIENT; RELAPSE; RISK FACTOR; SEX DIFFERENCE; SIBLING; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0034769482     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11669217     Document Type: Article

References (36)

1. Graft-versus-host disease
2. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease
3. Allogeneic marrow transplantation: The Seattle experience
4. Graft-versus-host disease
5. Limited polymorphism of minor histocompatibility loci in relation to bone marrow transplantation
6. Immunogenetics of human minor histocompatibility antigens: Their polymorphism and immunodominance
7. Isolation of human minor histocompatibility peptides
8. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease
9. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation
10. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants
11. Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein
12. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism
13. Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease
14. HLA-DRB typing using an in-house ELISA-based oligoprobe assay
15. Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: Results of a prospective double-blind randomized trial
16. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression
17. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors
18. Haplotype and linkage disequilibrium from the three locus phenotypes
19. Genetic and segregation analysis of the HL-A system
20. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation
21. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease
22. A randomized study of the prevention of acute graft-versus-host disease
23. Long-sought H-Y antigen found
24. Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate
25. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease
26. Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A*0201+ cytotoxic T cell line
27. Human memory CTL response specific for influenza A virus is broad and multispecific
28. Peculiar immunobiology of bone marrow allografts, II: Rejection of parental grafts by resistant F 1 hybrid mice
29. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
30. Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells
31. Peptide specificity in the recognition of MHC class I by natural killer cell clones
32. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
33. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation